TrumpRX: Medicare’s New Weight Loss Coke—Now in Pill Form!
In a twist messier than a TikTok diet challenge, the Trump administration is creeping towards a pharma bromance with Eli Lilly and Novo Nordisk to make weight loss drugs like Wegovy and Zepbound cheaper and Medicare-eligible. Imagine Wegovy dropping to $149/month on TrumpRX (official whitehouse-tool-for-shedding-bills) while Zepbound flexes at $299. Oh, and remember the April 2025 sabotage of Biden’s $40B idea to cover these magic needles? Yeah, now Trump’s shopping that buffet again, aiming to cover these drugs for both Medicare and possibly Medicaid users. Half of obese seniors were already halfway in before this saga even began.
Share the Story
(1 of 3)Trump's Medicare deal lets seniors lose weight for less while confusing the internet about who really hates spending big on drugs. Meanwhile, Wegovy and Zepbound are like the overpriced avocado toast of pharmaceuticals – now 'affordable' at hundreds a month!
Medicare covering weight loss drugs finally proves the government cares about more than just Twitter polls and obscure middle names.
Drug companies dropping prices on weight loss meds after politics does the math feels like your diet: inconsistent, overpriced, but somehow still hopeful.
Source: Axios | Published: 11/4/2025 | Author: Caitlin Owens
More Articles in Health
Motorola Razr Flip Phones Finally Told They’re Secure Enough for 2027
KPMG’s Consulting Business Dies Dramatically While Staff Take a Hike
America Tries Staying Cool While Secretly Preparing For Wattocalypse
90-Year-Old Dad Outsources Bathing to Jovial Nigerian and Ghanaian Carers
Woman Ages Backwards in Online Writing Class, Still Loses to 21-Year-Old
Billionaire’s Daughter’s Brain Hemorrhage Detected Belatedly By $299 Ring
Dietitians Unite to Demand We Eat More Beans, Save Humanity from Boredom
Mark Cuban Declares AI Too Empathetic to Replace Doctors, Only Bullshit Jobs Fear
